MedPath

The effects of aspirin on the platelet function of healty volunteers and of patients with occlusive arterial vascular disease.

Phase 4
Completed
Conditions
aspirin non-responders
aspirin resistance
10007963
10003216
Registration Number
NL-OMON31793
Lead Sponsor
Academisch Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

population A: healthy, BMI <27.5, non smoker.
Population B1: stroke in medical history (large vessel disease) between 01-07-01 and 01-07-06. No- recurrent stroke. Therapie with carbasalate calcium 100mg daily.
Population B2: recurrent stroke in medical history despite therapy with carbasalate calcium 100mg daily. First stroke between 01-07-01 and 01-07-06. last stoke > 3 months ago.

Exclusion Criteria

Population A: any contra-indication for carbasalate calcium. The use of NSAIDs. Cardiovascular disease, Diabetes Mellitus. recent operation (3 months)
Population B: therapy with clopidogrel, NSAIDs, oral anticoagulation therapy. Known malignancy, operation < 3 months ago. Cardiovascular event < 3 months ago. Known hematologic disease. Thrombocytopenia(< 100000/mm3), thrombocytosis (> 400 000/mm3), anemia, polycytemia (Ht>50%)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath